Stay updated on Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov record for a nivolumab-based treatment study in esophageal squamous cell carcinoma is now displayed instead of an access-denied page. It includes the study design and results-related measures, participant criteria, locations, and a study protocol document.
    Difference
    50%
    Check dated 2026-11-08T04:20:18.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0. The study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T01:06:45.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-25T01:06:43.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-18T00:56:07.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T01:17:49.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a minimal header and a Home link, replacing the usual study-record content for this URL. This indicates restricted access rather than new or updated trial information.
    Difference
    18%
    Check dated 2026-09-20T00:22:20.000Z thumbnail image

Stay in the know with updates to Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial page.